LLY Stock: Should You Buy After A 20% Rise?
We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...
BioPharma Dive16d
Lilly expands US manufacturing build-out with $50B target
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Hosted on MSN22d
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. The weight ...
Eli Lilly comes for knockoff weight loss drugs in new ad campaign
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday ...